DOSE-RESPONSE RELATIONSHIPS IN HEXACHLOROBENZENE-INDUCED PORPHYRIA

被引:11
|
作者
KENNEDY, SW [1 ]
WIGFIELD, DC [1 ]
机构
[1] CARLETON UNIV,OTTAWA CARLETON CHEM INST,OTTAWA K1S 5B6,ONTARIO,CANADA
关键词
D O I
10.1016/0006-2952(90)90407-C
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The rate of development of hexachlorobenzene (HCB)-induced porphyria in female Wistar rats was determined using HCB dosage and porphyrin analysis protocols designed to determine factors which contribute to the delay commonly observed between initial exposure to HCB and the detection of porphyria. Measurements were made of HCB and porphyrin concentrations in the livers, kidneys, and spleens of female Wistar rats exposed continuously (up to 56 days) or for 1 day to HCB (at dietary concentrations of 1000 ppm and 100 ppm). The experiments showed that when a corn oil solution of HCB was added to the diet at a concentration of 1000 ppm, HCB accumulated rapidly in all organs, and the delay in appearance of elevated liver highly carboxylated porphyrins (HCPs) was at most 4 days (approximately 8-fold elevation of HCPs on day 4). One day of exposure to this diet was sufficient to cause elevated liver HCPs, thus showing that continuous exposure to HCB was not required to cause porphyria in this species. Solid HCB added directly to the diet (1000 ppm) resulted in less rapid HCB accumulation and less rapid development of porphyria. The experiments demonstrated that the appearance of a delay in HCB-induced porphyria in the Wistar rat is caused by the rate at which HCB is absorbed, and by using total hepatic porphyrins (rather than HCPs) as the indicator of the disorder. The experiments also showed that HCB-induced liver enlargement and neurotoxicity are not necessarily associated with the severity of porphyria. © 1990.
引用
收藏
页码:1381 / 1388
页数:8
相关论文
共 50 条
  • [31] HEXACHLOROBENZENE-INDUCED PORPHYRIA IN JAPANESE QUAIL - EFFECT OF PRETREATMENT WITH PHENOBARBITAL OR BETA-NAPHTHOFLAVONE
    CARPENTER, HM
    WILLIAMS, DE
    HENDERSON, MC
    BENDER, RC
    BUHLER, DR
    BIOCHEMICAL PHARMACOLOGY, 1984, 33 (23) : 3875 - 3881
  • [32] CUTANEOUS CYTOCHROME-P-450 ACTIVITY DURING HEXACHLOROBENZENE-INDUCED EXPERIMENTAL PORPHYRIA IN RATS
    GOERZ, G
    VIZETHUM, W
    TSAMBAOS, D
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1979, 265 (01) : 111 - 114
  • [33] EPIDEMIOLOGY OF HEXACHLOROBENZENE-INDUCED PORPHYRIA IN TURKEY - CLINICAL AND LABORATORY FOLLOW-UP AFTER 20 YEARS
    PETERS, HA
    GOCMEN, A
    CRIPPS, DJ
    BRYAN, GT
    NEUROLOGY, 1981, 31 (04) : 111 - 111
  • [34] Dose-response relationships
    Dickerson, RL
    Brouwer, A
    Gray, LE
    Grothe, DR
    Peterson, RE
    Sheehan, DM
    Sills-McMurry, C
    Wiedow, MA
    PRINCIPLES AND PROCESSES FOR EVALUATING ENDOCRINE DISRUPTION IN SILDLIFE, 1998, : 69 - 96
  • [35] EPIDEMIOLOGY OF HEXACHLOROBENZENE-INDUCED PORPHYRIA IN TURKEY - CLINICAL AND LABORATORY FOLLOW-UP AFTER 25 YEARS
    PETERS, HA
    GOCMEN, A
    CRIPPS, DJ
    BRYAN, GT
    DOGRAMACI, I
    ARCHIVES OF NEUROLOGY, 1982, 39 (12) : 744 - 749
  • [36] HEXACHLOROBENZENE-INDUCED HYPERPARATHYROIDISM AND OSTEOSCLEROSIS IN RATS
    ANDREWS, JE
    COURTNEY, KD
    STEAD, AG
    DONALDSON, WE
    FUNDAMENTAL AND APPLIED TOXICOLOGY, 1989, 12 (02): : 242 - 251
  • [37] DOSE-RESPONSE RELATIONSHIPS FOR RADIATION-INDUCED HYPERPARATHYROIDISM
    SCHNEIDER, AB
    GIERLOWSKI, TC
    SHOREFREEDMAN, E
    STOVALL, M
    RON, E
    LUBIN, J
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (01): : 254 - 257
  • [38] The role of the immune system in hexachlorobenzene-induced toxicity
    Michielsen, CCPPC
    van Loveren, H
    Vos, JG
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1999, 107 : 783 - 792
  • [39] HEXACHLOROBENZENE-INDUCED PORPHYRIA IN JAPANESE-QUAIL - AN INVITRO STUDY OF CHANGES IN CYTOCHROME-P-450 AND MONOOXYGENASES
    CARPENTER, HM
    WILLIAMS, DE
    BUHLER, DR
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1985, 16 (02): : 207 - 217
  • [40] HEPATIC IRON STORES SUGGEST INCREASED DIETARY IRON-ABSORPTION IN EXPERIMENTAL HEXACHLOROBENZENE-INDUCED RAT PORPHYRIA
    FELDMAN, ES
    BRITTENHAM, GM
    HEPATOLOGY, 1985, 5 (05) : 1013 - 1013